Publications

Progesterone receptor modulates ERα action in breast cancer.

Authors: H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, AA Serand...

E-pub date: 16 Jul 2015

Journal name: Nature

Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis.

Authors: AL Paterson, JMJ Weaver, MD Eldridge, S Tavaré, RC Fitzgerald, PAW Edwards...

E-pub date: 10 Jul 2015

Journal name: BMC Genomics

Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.

Authors: A Irkle, AT Vesey, DY Lewis, JN Skepper, JLE Bird, MR Dweck, FR Joshi, FA G...

E-pub date: 7 Jul 2015

Journal name: Nat Commun

Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer.

Authors: SM Man, Q Zhu, L Zhu, Z Liu, R Karki, A Malik, D Sharma, L Li, RKS Maliredd...

E-pub date: 2 Jul 2015

Journal name: Cell

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Authors: M Sobral-Leite, J Wesseling, VTHBM Smit, H Nevanlinna, MH van Miltenburg, J...

E-pub date: 2 Jul 2015

Journal name: BMC Medicine

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.

Authors: K Sayal, I Gounaris, B Basu, S Freeman, P Moyle, K Hosking, M Iddawela, M J...

E-pub date: 1 Jul 2015

Journal name: Int J Gynecol Cancer

Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells.

Authors: AM Redmond, C Byrne, FT Bane, GD Brown, P Tibbitts, K O'Brien, ADK Hill, JS...

E-pub date: 1 Jul 2015

Journal name: Oncogene

PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.

Authors: HR Ali, S-E Glont, FM Blows, E Provenzano, S-J Dawson, B Liu, L Hiller, J D...

E-pub date: 1 Jul 2015

Journal name: Ann Oncol

Filters

Research Groups

Core Facilities

Start date

End date

Progesterone receptor modulates ERα action in breast cancer.

Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis.

Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.

Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.

Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells.

PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Progesterone receptor modulates ERα action in breast cancer.

Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis.

Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.

Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.

Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells.

PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.